Literature DB >> 12182955

G protein-dependent activation of mast cell by peptides and basic secretagogues.

Xavier Ferry1, Stephan Brehin, Rehab Kamel, Yves Landry.   

Abstract

Signaling pathways leading to exocytosis and arachidonate release from serosal mast cells by basic secretagogues, including cationic peptides, arise from the involvement of betagamma subunits from G(i2) and G(i3) GTP-binding proteins. The original concept that basic secretagogues directly interact with G proteins implicated the entry of secretagogues into mast cells. This has been demonstrated only for the neuropeptide substance P. Basic secretagogues might share a common mechanism of penetration with the newly described cell-penetrating peptides. The involvement of some membrane transporter or non-selective membrane receptor to basic secretagogues cannot be excluded. Copyright 2002 Elsevier Science Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12182955     DOI: 10.1016/s0196-9781(02)00090-6

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  39 in total

1.  An antimicrobial peptide with angiogenic properties, AG-30/5C, activates human mast cells through the MAPK and NF-κB pathways.

Authors:  Kazo Kanazawa; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

Review 2.  Approaches for analyzing the roles of mast cells and their proteases in vivo.

Authors:  Stephen J Galli; Mindy Tsai; Thomas Marichal; Elena Tchougounova; Laurent L Reber; Gunnar Pejler
Journal:  Adv Immunol       Date:  2015-02-07       Impact factor: 3.543

3.  The basic secretagogue compound 48/80 activates G proteins indirectly via stimulation of phospholipase D-lysophosphatidic acid receptor axis and 5-HT1A receptors in rat brain sections.

Authors:  Ville A B Palomäki; Jarmo T Laitinen
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

4.  Techniques for neuropeptide determination.

Authors:  Mats Sandberg; Stephen G Weber
Journal:  Trends Analyt Chem       Date:  2003-09       Impact factor: 12.296

Review 5.  Potential effector and immunoregulatory functions of mast cells in mucosal immunity.

Authors:  L L Reber; R Sibilano; K Mukai; S J Galli
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

6.  Innate defense regulator IDR-1018 activates human mast cells through G protein-, phospholipase C-, MAPK- and NF-ĸB-sensitive pathways.

Authors:  Kensuke Yanashima; Panjit Chieosilapatham; Eri Yoshimoto; Ko Okumura; Hideoki Ogawa; François Niyonsaba
Journal:  Immunol Res       Date:  2017-08       Impact factor: 2.829

7.  PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells.

Authors:  Hariharan Subramanian; Sakeen W Kashem; Sarah J Collington; Hongchang Qu; John D Lambris; Hydar Ali
Journal:  Mol Pharmacol       Date:  2011-03-11       Impact factor: 4.436

Review 8.  Roles of Mas-related G protein-coupled receptor X2 on mast cell-mediated host defense, pseudoallergic drug reactions, and chronic inflammatory diseases.

Authors:  Hariharan Subramanian; Kshitij Gupta; Hydar Ali
Journal:  J Allergy Clin Immunol       Date:  2016-07-20       Impact factor: 10.793

9.  Neuropeptides activate human mast cell degranulation and chemokine production.

Authors:  Marianna Kulka; Cecilia H Sheen; Brian P Tancowny; Leslie C Grammer; Robert P Schleimer
Journal:  Immunology       Date:  2007-10-06       Impact factor: 7.397

10.  Mast cells: pivotal players in cardiovascular diseases.

Authors:  Ilze Bot; Theo J C van Berkel; Erik A L Biessen
Journal:  Curr Cardiol Rev       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.